Merck granted U.S. Patents for Foundational CRISPR-Cas9 Technology A
leading science and technology company, Merck, announced that in the
United States, two of its CRISPR-Cas9-assisted genome-editing patents
have been allowed. In their work to advance and protect gene therapy
development programs, these allowances provide Merck with the
opportunity to support U.S. scientists and researchers. The […]
The post U.S. Patents for Foundational CRISPR-Cas9 Technology Granted
To Merck & Co. appeared first on BioTecNika .
https://www.biotecnika.org/2020/05/merck-granted-us-patents-for-foundational-crispr-cas9-technology/
Biotech News
No comments:
Post a Comment